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TRP (Transient Receptor Potential) cation channels of the TRPM subfamily have been
found to be critically important for the regulation of Mg2+ homeostasis in both protostomes
(e.g., the nematode, C. elegans, and the insect, D.melanogaster) and deuterostomes (e.g.,
humans). Although significant progress has been made toward understanding how the
activities of these channels are regulated, there are still major gaps in our understanding of
the potential regulatory roles of extensive, evolutionarily conserved, regions of these pro-
teins. The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel
proteins that are similar in sequence and function to human TRPM6 and TRPM7. We iso-
lated fourteen revertants of the missense mutant, gon-2(q338), and these mutations affect
nine different residues within GON-2. Since eight of the nine affected residues are situated
within regions that have high similarity to human TRPM1,3,6 and 7, these mutations identify
sections of these channels that are potentially critical for channel regulation. We also iso-
lated a single mutant allele of gon-2 during a screen for revertants of the Mg2+-hypersensi-
tive phenotype of gtl-2(-)mutants. This allele of gon-2 converts a serine to phenylalanine
within the highly conserved TRP domain, and is antimorphic against both gon-2(+) and gtl-1
(+). Interestingly, others have reported that mutation of the corresponding residue in TRPM7
to glutamate results in deregulated channel activity.
Introduction
The TRP (Transient Receptor Potential) superfamily of eukaryotic cation channels comprises
seven subfamilies: TRPA, TRPC, TRPM, TRPML, TRPN, TRPP and TRPV [1–3]. In all cases,
channel activity is thought to result from the association of four subunits, each of which has six
transmembrane domains (S1–S6), an S5–S6 pore-lining segment, and cytoplasmic N- and C-
termini. The cytoplasmic N and C terminal domains that flank S1–S6 tend to be quite different
between different TRP protein subfamilies, with the "TRP domain" (~25 aa immediately after
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S6) being a notable exception. In some of the TRPM subfamily members, the most C-terminal
region has acquired an enzymatic domain: TRPM2 has an ADP-ribose hydrolase domain [4],
whereas TRPM6 [5, 6] and TRPM7 [7–9] have an alpha-kinase domain. These domains may
play regulatory roles, but enzymatic activity per se is not required for channel activity [10–13].
The functions of different regions of TRP channels have been inferred through a variety of
methods, including comparison with previously characterized protein motifs e.g., [4, 7, 14],
sequencing of disease-causing alleles, e.g., [15–17], site-directed mutagenesis of candidate regu-
latory residues, e.g., [18–20], and in vivo selection for variants with altered activity,.e.g., [21,
22]. Recently, high resolution structural data have been published for TRPVI [23, 24] and
TRPA1 [25], confirming the tetrameric structure prediction and highlighting the importance
of the TRP domain for channel gating. The structural data also revealed additional sequences
in TRPV1 and/or TRPA1 that are important for the regulation of channel activity, such as the
"pre-S1 helix" and adjacent linker sequence, discussed further below. In the case of TRPM
channels, relatively low resolution structural data are available for TRPM2, and these suggest
extensive interactions between the N- and C-terminal cytoplasmic domains, similar to that
reported for TRPA1 [26].
The genome of the nematode, Caenorhabitis elegans, contains three paralogous genes, gon-
2, gtl-1 and gtl-2, which encode cation channel proteins (GON-2, GTL-1 and GTL-2) that are
similar to human TRPM6 and TRPM7, but lack the kinase domain. Like TRPM6 and TRPM7,
the channels formed by GON-2, GTL-1 and GTL-2 are permeable to the divalent cations, Ca2+
and Mg2+, and play a role in the systemic regulation of Mg2+ that is conserved in humans, Dro-
sophila and nematodes [6, 27–31]. GON-2 and GTL-1 are both expressed in the intestine and
act semi-redundantly to mediate the uptake of Mg2+ from the gut lumen. gon-2(lf); gtl-1(0)
(i.e., gon-2 loss-of-function; gtl-1 null) animals are unable to grow unless the medium is supple-
mented with high levels of Mg2+. GON-2 probably also functions in the somatic gonad precur-
sor cells, since these cells fail to proliferate in gon-2(lf)mutants [32]. GTL-2 is expressed in
both the hypodermal cells and the excretory cell and is required for clearance of excess Mg2+
via the excretory system [31, 33]. gtl-2(0)mutants are unable to grow if the medium is supple-
mented with high levels of Mg2+.
We have performed extensive genetic screens for mutations that suppress the gonadogenesis
defect of gon-2(q388ts)mutants, and these resulted in the identification two new loci, gem-1
[34] and gem-4 [35]. During these screens, we also identified multiple intragenic suppressor
mutations within gon-2, and these are described in this paper. We have also screened for muta-
tions that suppress the Mg2+ sensitive phenotype of gtl-2(0)mutants, and this resulted in the
identification multiple loss-of-function alleles of gtl-1 [31], plus an unusual antimorphic allele
of gon-2, which is described here. Together, these mutations in gon-2 highlight a series of resi-
dues that are potentially important for TRPM channel regulation. In some cases, these are in




C. elegans culture and genetic manipulations were performed essentially as described previ-
ously [31, 32, 34].
Molecular biology
Standard methods were used to PCR amplify and sequence genomic DNA from C. elegans.
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Amino acid alignments
The software package CLC Main Workbench v. 6.6.5 (www.clcbio.com) was used to perform
amino acid alignments for graphical output.
Strains
The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X;
EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc-
13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116)
unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1
(bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190
gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13
(e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.
Dosage testing
Strain LX929 vsIs48[Punc-17::gfp] X, which expresses GFP in all cholinergic neurons, was
obtained fromMichael Koelle (Yale University). LX929 (N2) males were mated with wild type
CB4856 (Hawaiian) males, and vsIs48 homozyous hermaphrodites were reisolated from the F2
to generate strain EJ1173. Males of this strain retain the vigorous mating ability of CB4856.
EJ1173 males were crossed with gon-2(q388) hermaphrodites and gon-2(q388); vsIs48 her-
maphrodites were isolated from the F2 to generate strain EJ1190. These males are also vigorous
maters and were used for the dosage experiments as follows. L4-stage hermaphrodites of geno-
type gon-2(q388sup) (i.e., intragenic revertant/suppressor alleles of gon-2(q388)) were incu-
bated overnight at 23 C, then transferred to a cross plate containing multiple EJ1190 males.
Incubation was continued at 23 C, and adults were transferred to a new plate after approxi-
mately 8 hrs, then removed 14 hours later. F1 hermaphrodite progeny were scored when they
reached adulthood, with cross progeny uniquely identifiable due to the dominant vsIs48
marker. Self progeny data were collected in parallel using GFP negative animals and/or plates
where no cross was performed. All gon-2(q388sup) alleles except dx116 were outcrossed once
or more before testing suppression efficiency.
Divalent cation depleted media (DCDM)
10 g of Agar (Carl Roth, Kobe I) was washed first with 500 ml of 20 mM EDTA, then three
times with deionized water to remove most divalent cations. This was then used to prepare
solid growth medium of the following final composition: 2% Agar, 4 mg/ml BactoTryptone
(Difco), 25 mMHEPES pH7.4, 25 mM NaCl, 5 micrograms/ml cholesterol. 1MMgSO4 and
1M CaCl2 stock solutions were added in appropriate amounts for Mg
2+ and Ca2+ supplementa-
tion experiments.
Genetic characterization of gon-2(dx87) and comparison with gon-2
(ok465)
Hermaphrodites of genotype unc-13(e51) gon-2(ok465)/unc-13(e51) lin-11(n566) were crossed
with EJ1173 males and multiple non-Unc L4-stage hermaphrodites were transferred to DCDM
plates and incubated at 23 C. unc-13(e51) gon-2(ok465) F2 hermaphrodites (distinguishable
due to their sterility) were scored as adults. Essentially the same procedure was followed for
unc-13(e51) gon-2(dx87)/+ + hermaphrodites, but F1s were not singled since all had the same
genotype.
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Results and Discussion
Reversion of gon-2(q388)
Although we isolated multiple loss-of-function alleles of gon-2 during our initial characteriza-
tion of this gene, most of our studies have utilized the gon-2(q388) allele [32]. This allele is
advantageous, because all animals are fertile when raised at permissive temperature (15°-20°C),
but nearly all (>90%) are gonadless (Gon)/sterile when raised at restrictive temperature
(> 23°C). In dosage tests, gon-2(q388) exhibits very little activity at restrictive temperature.
However, gon-2(q388) does evidently retain a low level of activity under restrictive conditions,
because it can be suppressed by gem-4(lf)mutations, unlike the null/deletion allele, gon-2
(ok465) [35]. gon-2(q388) converts a highly-conserved acidic residue (Glu) within the N-termi-
nal cytoplasmic domain of GON-2 to a basic residue (Lys) (Fig 1) [36]. The results of reciprocal
temperature shift experiments, suggest that gon-2(q388) probably affects a transient, irrevers-
ible process that is necessary for GON-2 stability, e.g., protein folding and/or channel assembly
[32].
Intragenic revertants of gon-2(q388ts) were obtained by selecting for fertile derivatives at
restrictive temperature after mutagenizing with EMS or 310 nm UV irradatiation, essentially as
described previously [34, 35]. Some screens included the gem-1(bc364)mutation, which
enhances the penetrance of gon-2(q388) [34]. In the case of mutations that were found to be
linked to gon-2 during outcrossing, the gon-2 coding sequence was PCR amplified and
sequenced. The frequency of intragenic revertants was approximately 5 x 10−4 per mutagenized
genome. We did not find any cases in which the q388mutation had directly reverted back to
the wild type sequence. Possibly, this is because direct reversion would require a T -> C transi-
tion mutation, which is not favored by either EMS or 310 nm UV treatment.
Genetic characterization of intragenic revertants
The suppression efficiency of representative intragenic revertants was assessed by selfing
homozygous gon-2(q388sup) hermaphrodites at restrictive temperature and scoring the gona-
dogenesis phenotype of the progeny. The efficiency of suppression ranges from 85% (dx99) to
100% (dx146) (Table 1). This group of intragenic revertant mutations was also tested for haplo-
sufficiency by crossing homozygous gon-2(q388sup) hermaphrodites with gon-2(q388)males at
restrictive temperature and scoring the offspring. gon-2(q388) has very little activity under
these conditions, so this assay provides a good measure of dosage sensitivity of gon-2(q388sup)
alleles. The strength of suppression among animals heterozygous for the suppressor alleles cor-
relates well with the suppression efficiency measured for the homozygous strains (Table 1). In
most cases, suppression efficiency is slightly lower when the intragenic revertant mutation is
heterozygous, indicating that these alleles do not fully restore wild type gene function. How-
ever, gon-2(q388dx146) fully suppresses the gonadogenesis defect of gon-2(q388), even when
present in only a single dose.
Molecular characterization of intragenic revertant mutations
The locations of mutant alleles of gon-2 relative to the predicted protein topology are shown in
Fig 1. Most sites were identified by only a single mutation, indicating that the screen is not near
saturation. The codon for E996 appears to contain a mutational hotspot, since the identical C
-> T mutation was obtained independently as five different alleles, dx115, dx116, dx129, dx130
and dx147 (only dx116 is indicated in Fig 1). Most of the revertant mutations are relatively
near gon-2(q388) within the N-terminal cytoplasmic domain. Consistent with the idea that this
area is preferentially affected, dx148 (K991Q) and dx65(K991E) cause different alterations to a
Novel Alleles of a TRPMChannel
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Fig 1. Topology map of GON-2 (2032aa) with locations and aa changes of mutations. The inactivating
mutations, q388 and dx87, are shown in bold.
doi:10.1371/journal.pone.0143445.g001
Table 1. Dosage Testing of Intragenic Revertant Mutations.
Allele Configuration % Vul % Evul %WT n
gon-2(q388)/gon-2(q388)1 93 5 2 553
gon-2(q388dx60)/gon-2(q388dx60)2 7 4 89 124
gon-2(q388dx60)/gon-2(q388) 11 8 81 132
gon-2(q388dx99)/gon-2(q388dx99)3 10 5 85 124
gon-2(q388dx99)/gon-2(q388) 24 15 51 164
gon-2(q388dx116)/gon-2(q388dx116)4 0 0 100 140
gon-2(q388dx116)/gon-2(q388) 0 5 95 153
gon-2(q388dx146)/gon-2(q388dx146)5 0 0 100 516
gon-2(q388dx146)/gon-2(q388) 0 0 100 583
gon-2(q388dx65)/gon-2(q388dx65)6 9 1 90 238
gon-2(q388dx65)/gon-2(q388) 23 8 69 159
gon-2(q388dx148)/gon-2(q388dx148)7 0 0.5 99 223
gon-2(q388dx148)/gon-2(q388) 0 1 99 257
Allele configuration is for animals derived from selfing or crosses, as described in Materials and Methods.
Full genotypes of parental strains are listed in Materials and Methods. Vulvaless (Vul) animals have a
severe gonadogenesis (Gon) phenotype, whereas Everted vulva (Evul) animals have a less severe defect










Novel Alleles of a TRPMChannel
PLOS ONE | DOI:10.1371/journal.pone.0143445 November 25, 2015 5 / 16
single residue within this region. In each case, it is possible that the intragenic revertant muta-
tion acts by somehow compensating for the effects of the gon-2(q388)mutation on protein
folding/channel assembly. However, in the descriptions below, we focus on the potential signif-
icance of the mutations with regard to effects on channel activity that are independent of the
effects gon-2(q388).
dx146. This mutation alters a tyrosine residue that is also found in mammalian
TRPM1,3,6,7 and Drosophila TRPM (DTRPM) (Fig 2). This is a candidate Src phosphoryla-
tion site YT [37] that could potentially affect channel localization, turnover, or inter-subunit
interaction. Notably, the N-terminal cytoplasmic domain of TRPM6 contains multiple
ankyrin-like domains that are likely to mediate interaction between channel subunits [38]. For
example, the S141L mutation in human TRPM6 affects one of these ankyrin repeats and pre-
vents channel subunit assembly, thus leading to hereditary Mg2+ deficiency [39].
dx65, dx148. These mutations both affect the same, highly conserved lysine residue
(K991), relatively close to gon-2(q388) K955E (Fig 3). Lysines are candidate sumoylation sites,
and sumoylation status is known to affect the activity of TRPM proteins [40]. However, this is
probably not the basis for the effects of dx65 and dx148, since they produce quantitatively dif-
ferent results (Table 1) even though each eliminates the candidate sumoylation site.
Additionally, of possible significance is the report by Stallmeyer et al. that in certain individ-
uals with a putative gain-of-function mutation in TRPM4, a nearby conserved glycine is con-
verted to serine (G582S; Fig 3) [41]. However, other amino acid alterations within TRPM4
were also present in these individuals, so it is uncertain whether G582S increases, decreases or
has no effect on TRPM4 activity.
dx116 and dx151. These mutations affect residues immediately downstream of dx65/
dx148 (Fig 3), converting a moderately conserved glutamate to lysine (dx116, E996K) and a
non-conserved aspartate to tyrosine (D1000Y).
dx96 and dx150. These affect a highly conserved acidic residue (dx96 D1033N) and a
non-conserved acidic residue (dx150 E1050K) within a region that is important for TRPM6
activity (Fig 4). Jalkanen et al. identified the C707Y allele [42] and Lainez et al. identified the
L708P allele [43] in patients with hypomagnesemia and secondary hypercalcemia (HSH). Lai-
nez et al. found that the L7808P mutation severely impairs channel activity, but does not affect
expression and trafficking, leading them to speculate that this region is required for proper
interaction between channel subunits [43]. This region of TRPV1 forms a linker domain that is
situated between the N-terminal ankyrin repeats and the pre-S1 helix [24]. Notably, G375 and
G376 in TRPV1 mediate direct interaction between the linker domain and the N-terminal
ankyrin repeats of ajdacent subunits [24]. The sequence identity between TRPM and TRPV
proteins is very low in this region; however, ankyrin-like repeats do exist in the N-terminal
cytoplasmic domain of TRPM6 and 7 [38].
dx177. This mutation converts an aspargine to aspartate. No alignment is shown because
the alteration occurs in a section of GON-2 that has similarity only to GTL-1.
dx60. This mutation converts an atypical threonine to lysine (Fig 5). Interestingly, this
appears to represent a return to an ancestral state, since lysine is present at this position in
GTL-2, as well as in the most closely related TRPM channels from mammals and Drosophila.
dx60 is situated at the end of the "pre-S1 helix" [24]. In TRPV1, this region interacts directly
with with the TRP domain, probably to maintain channel closure. Although this region of
TRPM channels is not highly similar to TRPV1, it is predicted to have helical structure [44].
Therefore, dx60 could potentially render the GON-2 channel more active by increasing its
open probability. Of additional possible significance is that fact that pre-S1 helix region of
GON-2 contains a sequence (QGTRKKIKMRRRFYEFYSAPI) that is predicted to bind to cal-
modulin (http://calcium.uhnres.utoronto.ca/ctdb/ctdb/sequence.html). Conceivably,
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calmodulin could compete with the TRP domain for binding to the pre-S1 helix and this could
explain the ability of low levels of cytoplasmic Ca2+ to activate GON-2 [45].
In the case of TRPM4, the pre-S1 helix interacts with phosphoinositides that modulate
channel gating [46], so this is another protential regulatory mechanism that could be affected
by dx60.
Fig 2. Alignment of representative TRP channel protein sequences near the site of the gon-2(dx146)
mutation. The following GenBank accession numbers (or UniProt identifiers) were used to retrieve amino
acid sequences of proteins shown in alignments. Human proteins: TRPV1 Q8NER1, TRPV3 Q8NET1,
TRPC5Q9UL62, TRPM1 NP_001238949, TRPM2 XP_011528036, TRPM3 NP_060132, TRPM4
NP_060106, TRPM5 NP_055370, TRPM6 NP_060132, TRPM7 NP_060142, TRPM8 NP_076985.C.
elegans proteins: GON-2 CAB02303, GTL-1 CAA92726, GTL-2 CAB00861. Drosophila melanogaster
protein: DTRPM A8DYE2.
doi:10.1371/journal.pone.0143445.g002
Fig 3. TRP protein alignment from gon-2(q388)-gon-2(dx151).
doi:10.1371/journal.pone.0143445.g003
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Also of potential significance, Ubipred[47] predicts that 3 of the 8 high-confidence ubiqui-
tylation sites in GON-2 (K1255, K1269 and K1272) are situated nearby. A decrease in ubiqui-
tlyation efficiency would be expected to result in increased channel expression on the plasma
membrane [48–50].
dx99. This mutation converts a moderately conserved glutamate to lysine (Fig 6). This
region of the protein is notable for multiple reasons. First, Lainez et al. identified the L1143P
mutation of TRPM6 in a patient with HSH [43], and found that while the mutation severely
impairs channel activity, it does not affect expression and/or trafficking. Second, two of the
eight high-confidence candidate ubiquitylation sites within GON-2 are in this region, K1655
and K1659 [47]. Third, R721 of TRPV1 is required for channel activation by specific
Fig 4. TRP protein alignment from gon-2(dx96)—gon-2(dx150).
doi:10.1371/journal.pone.0143445.g004
Fig 5. TRP protein alignment near gon-2(dx60).
doi:10.1371/journal.pone.0143445.g005
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phosophoinositides, probably via direct interaction [51]. The corresponding residue within
GON-2 is situated within a high-confidence calmodulin binding sequence (LYHGVLILQFVR
TRLSCSKS; http://calcium.uhnres.utoronto.ca/ctdb/ctdb/sequence.html).
Several studies suggest that this region of GON-2 is likely to mediate direct interaction
between channel subunits via the formation of coiled coils. Mei et al., showed that a predicted
coiled-coil forming region of TRPM2 (beginning approximately 20 aa after the residue affectd
by dx99) is required for association between channel subunits [52, 53]. Fujiwara et al. [54] per-
formed structural studies demonstrating that the corresponding region of TRPM7 can form
anti-parallel coiled-coils. Finally, Paulsen et al. showed that an overlapping ~80 aa region of
TRPA1 forms parallel coiled coils that mediate association between channel subunits [25].
When analyzed by JPRED4 [44], this region of TRPA1 is predicted to be mostly helical, but
with multiple interruptions. Significantly, JPRED4 predicts that an 88 amino acid segment of
GON-2 that includes the site of dx99 (NDQIEKLHDFEEDCMEDLARQKLNEKNTSNEQRIL
RADIRTDQILNRLIDLQAKESMGRDVINDVESRLASVEKAQNEILECVRALLN) is likely to
be entirely helical except for a small gap (underlined residues). This is also true for TRPM6 and
TRPM7, so this is likely to be a conserved structural feature that has the potential to mediate
an extensive coiled-coil interaction between subunits. In summary, dx99 could potentially
affect gon-2(q388) activity by reducing ubiquitylation efficiency, altering affinity for regulatory
phosphoinositides, or by potentiating successful channel assembly.
Reversion of gtl-2(0)
gtl-2(tm1463) animals were mutagenized with EMS and then Mg2+-resistant revertants were
selected as described [31]. In the case of one of the revertant mutations, dx154, we observed
Gon animals at high frequency during outcrossing. Through standard mapping and comple-
mentation testing we determined that dx154 was an allele of gon-2. Upon sequencing the cod-
ing reqions of gon-2, we found a single C->T mutation corresponding to gon-2(dx154). This
mutation is identical to gon-2(dx87), which we identified in a previous screen for Gon mutants
[36].
Two lines of evidence suggest that gon-2(dx154) is not a simple loss-of-function allele. First,
the loss-of-function allel, gon-2(q388), does not suppress the Mg2+ sensitivity of gtl-2(tm1463)
Fig 6. TRP protein alignment near gon-2(dx99).
doi:10.1371/journal.pone.0143445.g006
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mutants. Second, we isolated only a single allele of gon-2 in this screen, whereas we identified
multiple loss-of-function alleles of gtl-1, a gene of similar size.
The ability of gon-2(dx154) to suppress gtl-2(tm1463) can be explained most simply if gon-2
(dx154) produces an antimorphic protein that is capable of interfering with GTL-1 activity.
This is consistent with the tetrameric structure of TRPM channels, and supports that idea that
GON-2 and GTL-1 are able to form heterotetramers.
Genetic characterization of gon-2(dx87). We used a stock carrying the gon-2(dx87)
mutation (identical to dx154) to test whether this allele is able to interfere with the activity of
gon-2(+). In order to do this, we examined the gon-2(dx87) homozygous progeny of gon-2
(dx87)/+ heterozygous hermaphrodites, comparing these with gon-2(0) (ok465) homozygous
progeny from gon-2(0)/+ hermaphrodites (Table 2, lines 6 and 7). Due to maternally contrib-
uted gon-2(+) gene product, gon-2(0) homozygotes are almost always able to execute a suffi-
cient number of gonadal cell divisions to generate an anchor cell, and thus induce the
underlying hypodermal cells to produce a vulva. However, 100% of gon-2(dx87) homozygous
progeny of a heterozygous mother are vulvaless. Therefore, gon-2(dx87) is able to interfere
with gon-2(+) in addition to gtl-1(+). gon-2(dx87) is not strongly antimorphic, because gon-2
(dx87)/gon-2(+) progeny of a gon-2(dx87) homozygous mother always undergo normal devel-
opment (Table 2, line 3).
One striking feature of gon-2(dx87) is that its effects on gonad development can be sup-
pressed even by a low level of Mg2+ in the medium (1 mM; Table 2 lines 4–6). This is interest-
ing, because it suggests that gon-2(dx87) homotetramers are able to permeate Mg2+ effectively
into the gonad precursors. However, since gon-2(dx154) (= dx87) was isolated based on its abil-
ity to suppress the toxic hyperaccumulation of Mg2+ in gtl-2(-) animals that are grown on high
Mg2+, heterotetrameric complexes that contain both GON-2(dx87) and GTL-1 are probably
significantly less active than heteromeric complexes that contain only wild type proteins.
Possible mechanisms of action of gon-2(dx87). dx87converts a well-conserved serine
within the TRP domain to a phenylalanine (Fig 7). Hofman et al. [55] showed that mutation of
the corresponding serine residue of TRPM7 (S1107) to glutamate caused the channel to be con-
stitutively active and insensitive to high concentrations (2 mM) of intracellular Mg2+. Similarly,
Luo et al. showed that changing E682 of TRPV3 to either glutamine or asparagine caused the
channel to be significantly less sensitive to inhibition by intracellular Mg2+ [56]. Furthermore,
Lin et al. identified the W692G of TRPV3 mutation in patients with Olmsted syndrome and
showed that this mutation causes the channel to be constitutively active [57]. They suggested
that, as in voltage-gated potassium channels, the region immediately C-terminal to S6 can
interact with the S4–S5 cytoplasmic loop to maintain a closed channel state. In the case of
TRPC5, Obhukov et al. [20], found that D633 and D636 mediate channel blockage by intracel-
lular Mg2+ at positive voltages. Although these are not physiological conditions, these data
again suggest that Mg2+ may interact directly with the TRP domain to maintain a closed chan-
nel state, possibly by promoting interactions between the TRP domain and one or more other
cytoplasmic segments (S4–S5 loop, pre-S1 helix).
Additional factors are also likely to interact with the TRP domain. For example, Xie et al.
[58] showed that R1088 of TRPM6 R1088 is required for full activation by PI(4,5)P2. Two
other basic residues nearby are also important, but these are not conserved in GON-2. Further-
more, in the case of TRPV1, Poblete found that K694 interacts with phospho-head group of PI
(4,5)P2 [59]. Ca2+ probably also interacts with the TRP domain; Yamaguchi et al. showed that
mutation of either E1062 or D1039 reduced the activation of TRPM4 by intracellular Ca2+, and
argued that Ca2+ interacts directly with these residues [60]. It is also worth noting that Liu et al.
found that the Brugada Syndrome L1075P allele of TRPM4 resulted in an increase in the
amount of protein present on cell surface, suggesting a defect in endocytic trafficking [61].
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Studies in C. elegans, indicate that GON-2 activity is regulated by each of the factors dis-
cussed above. Estevez et al. [45, 62] reported that outward currents through GON-2/GTL-1
(i.e., ORCa, [63]) are inhibited by submillimolar intracellular Mg2+, stimulated by relatively
low intracellular Ca2+ (11 nM), and inhibited by higher levels of intracellular Ca2+ (250 nM).
Based on steric considerations, they concluded that the likely site of inhibitory interaction with
Ca2+ is in close proximity to the plasma membrane/channel pore, i.e, possibly within the TRP
domain. In a subsequent study from the same group, Xing et al., [64] showed that PLC gamma
activates GON-2/GTL-1, and that this effect probably results from a decrease in the concentra-
tion of PI(4,5)P2. Their results also indicated that the inhibitory effects of PI(4,5)P2 and Ca2+
on GON-2/GTL-1 are independent, and thus probably mediated by separate sites on the chan-
nel. In a separate study, Teramoto et al. [30] performed electrophysiological characterization of
Table 2. Effects of gon-2(dx87) on gon-2(+)Activity and in Response to Different Divalent Cation Concentrations.
Maternal Allele Configuration Zygotic Allele Configuration Mg2+ Ca2+ Gon Evul wt n
1 gon-2(dx87/gon-2(+) gon-2(dx87/gon-2(dx87) 0 0 95 4 1 81
2 gon-2(ok465)/gon-2(+) gon-2(ok465)/gon-2(ok465) 0 0 3 12 85 103
3 gon-2(dx87/gon-2(dx87) gon-2(dx87/gon-2(+) 0 0 0 0 100 151
4 gon-2(dx87/gon-2(dx87) gon-2(dx87/gon-2(dx87) 0 0 100 0 0 253
5 gon-2(dx87/gon-2(dx87) gon-2(dx87/gon-2(dx87) 1 0 0 3 97 177
6 gon-2(dx87/gon-2(dx87) gon-2(dx87/gon-2(dx87) 10 0 0 0 100 425
7 gon-2(dx87/gon-2(dx87) gon-2(dx87/gon-2(dx87) 1 10 89 5 5 340
Crossing schemes, full parental genotypes and culture conditions are described in Materials and Methods. Supplemental ion concentrations (in mM) are
indicated. It should be noted that all strains were propagated on living E. coli, which contains at least trace amounts of Ca2+ and Mg2+, even when grown
on divalent cation depleted medium.
doi:10.1371/journal.pone.0143445.t002
Fig 7. TRP protein alignment near gon-2(dx87).
doi:10.1371/journal.pone.0143445.g007
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cells isolated from gon-2(-) and gtl-1(-) animals, as well as physiological experiments with sin-
gle and double mutant animals, and thus were able to ascribe specific properties to the individ-
ual GON-2 and GTL-1 channels. Their key findings were that the GON-2 channel is inhibited
by intracellular Mg2+ levels above 1 mM, whereas GTL-1 is not inhibited even at 6 mM intra-
cellular Mg2+. gon-2(-) animals (which possess only GTL-1 activity) are relatively insensitive to
growth inhibition by 10 mM Ca2+ in the medium, whereas gtl-1(-)mutants (which possess
only GON-2 activity) grow very slowly under these conditions. Therefore, GON-2 is more sen-
sitive than GTL-1 to inhibition by Ca2+. Furthermore, the growth defect of gtl-1(-)mutants on
0 mM supplemental Mg2+ could be rescued by 5 mM EGTA, which preferentially chelates
Ca2+. It is unclear whether this inhibitory effect of Ca2+ is due to intracellular or extracelluar
effects on GON-2.
One simple explanation for the effects of gon-2(dx87) would be that it destroys a residue
that facilitates intracellular exit of divalent cations from the channel pore. This would be a logi-
cal consequence of the removal of the polar serine residue and/or introduction of the bulky
hydrophobic phenylalanine residue. Alternatively, gon-2(dx87) could increase the affinity of
the TRP domain for binding by a negative regulator, e.g., PI(4,5)P2, Mg2+ or Ca2+. Our data do
not allow us to determine whether or not GON-2(dx87) is inhibited normally by intracellular
Mg2+. However, GON-2(dx87) is clearly sensitive to inhibition by Ca2+, because the addition of
10 mM Ca2+ to medium that contains 1 mMMg2+ causes an increase in the frequency of Gon
animals from 0% to 89% (Table 2, line 7).
Conclusions
In this study, we have identified seven evolutionarily conserved residues in the N-terminal
cytoplasmic domain of GON-2, and one residue in the C-terminal cytoplasmic domain, as
potentially important regulators of channel activity. Since each of these mutations was isolated
as an intragenic revertant of the gon-2(q388) loss-of-function mutation, we do not know
whether these mutations would affect channel activity when present in an otherwise wild type
GON-2 protein. Furthermore, since our analyses are based on phenotypic output, we do not
know the mechanism whereby these mutations affect channel activity, e.g., via altering protein
folding, channel subunit trafficking, oligomeric assembly, or channel gating. We have also
identified an unusual antimorphic allele of gon-2 that converts a highly conserved serine resi-
due within the TRP domain to phenylananine. It is particularly intriguing that this Hofman
et al. [55] showed that changing the corresponding residue of TRPM7 to glutamate resulted in
a channel that was consitutively active, even in the presence of high intracellular Mg2+. There-
fore, this residue appears to be positioned at a key site involved in channel gating.
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